Phosphofructokinase activity in skeletal muscle extracts following administration of epinephrine.
D000249:Adenosine Monophosphate; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000494:Allosteric Regulation; D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D002606:Charcoal; D000242:Cyclic AMP / Q000494:pharmacology; D004789:Enzyme Activation; D004837:Epinephrine / Q000494:pharmacology*; D005636:Fructosephosphates / Q000494:pharmacology; D005958:Glucosephosphates; D006863:Hydrogen-Ion Concentration; D008297:Male; D009132:Muscles / Q000187:drug effects / Q000201:enzymology*; D009206:Myocardium / Q000201:enzymology; D010732:Phosphofructokinase-1 / Q000037:antagonists & inhibitors / Q000302:isolation & purification / Q000378:metabolism*; D011485:Protein Binding; D011817:Rabbits; D012756:Sheep
D005636:Fructosephosphates; D005958:Glucosephosphates; D002606:Charcoal; D002110:Caffeine; D000249:Adenosine Monophosphate; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D010732:Phosphofructokinase-1; D004837:Epinephrine